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Reprocessing Single-Use Devices    
Legislative issues in the EU
Reprocessing single-use medical devices 
raises issues of patient safety, ethics, the 
environment and costs. The aim of this paper 
is to raise awareness of the problems related 
to the reprocessing of single-use medical 
devices in the EU, with a focus on Portugal’s 
position regarding this issue.
With the technology evolution, medical devices 
increasingly became more complex and difficult 
to clean and sterilise. In response, single-use 
medical devices were developed. Due to 
economic factors, hospitals and companies  
now practice the reprocessing of single-use 
medical devices. This raises important issues 
concerning patient safety, ethics, the 
environment and costs (Abreu I, Abreu M J, 
Coelho A, 2014). 
Medical devices were initially intended to be 
reusable, as was favoured by their design, size, 
shape, and manufacture from materials that 
could withstand sterilisation. In 1948, the first 
single-use medical device was developed 
(Cohoon, 2002). 
As technology developed, so too did medical 
devices becoming more complex and 
sophisticated, with specific characteristics and 
properties. Devices with polymeric compounds 
were resistant neither to physical and chemical 
aggressive treatments, nor to high temperatures 
and, hence, were not resistant to sterilisation 
processes. Also, new devices for mini-invasive 
procedures were developed with narrower 
diameters and more intricate and delicate 
mechanisms. Some of these devices can be 
difficult to clean and sterilise properly, 
rendering manufacturers unable to demonstrate 
safe reuse. For this reason, some devices are 
labelled with the designation ‘single use’. 
Interest in these products swelled with the 
appearance of HIV and hepatitis transmission 
(Dunn, 2002). Consequently, the use of single-
use medical devices has considerably increased 
in hospitals, in particular to reduce the risks of 
cross contamination between patients. 
Definition and classification of single-use 
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medical devices emerged in Council Directive 
93/42/EC concerning medical devices was 
adopted on 14 June 1993 and amended by 
Directive 2007/47/EC as “a device intended to 
be used once only for a single patient”.
In the last few years, hospitals have been faced 
with financial changes resulting in the need to 
reduce costs. In response, many hospital 
entities are now exploring the reprocessing and 
reuse of single-use products. 
Council Directive 93/42/EEC amended by 
Directive 2007/47/EC does not define 
reprocessing, but instead imposes the need to 
ensure that the reprocessing of medical devices 
does not constitute a danger to the safety or 
health of patients by clarifying the definition of 
‘single use’ and the establishment of labelling 
and instructions for uniform use. 
With regards to reusable devices, the Council 
Directive only states that “if the device is 
reusable, information must be provided on the 
appropriate processes to allow reuse, including 
cleaning, disinfection and packaging and, if 
applied, the method of sterilisation of the 
device to be re-sterilised and any restriction on 
the number of reuses.” 
European variations
Council Directive 93/42/EEC of 14 June 1993 
amended by Directive 2007/47/EC concerning 
medical devices establishes laws that all 
countries in the EU must follow regarding 
product conception, manufacture, 
commercialisation and entry into service. Each 
country then transposes the Directive to its 
national legislation.
Different health institutions across Europe have 
practiced reprocessing of single-use medical 
devices, and it has received special attention 
from the Competent Authorities of each 
country. The reprocessing practice of single-use 
medical devices is not currently regulated at the 
community level; instead, different national 
legislations regulate this practice throughout 
Europe. Few countries allow the practice and 
have developed guidelines; in other countries it 
is prohibited. The majority of Member States 
do not have any specific regulation on this 
aspect (European Commission, 2010). As seen 
in Table 1, the position concerning reprocessing 
of single-use medical devices is held at the 
legislative level of each EU country.
Reprocessed single-use medical devices could 
introduce an increased risk to the patient when 
compared to the use of a new single-use device. 
It is important, therefore, to take into account 
the issue of information available to the patient 
and their informed consent before being 
subjected to a medical procedure involving 
reprocessed devices. Reprocessing of single-use 
medical devices raises ethical issues in terms of 
potential inequalities between patients. With 
regards to legal responsibility, it is necessary to 
clarify the responsibilities of each intervenient 
and inform health professionals in case of using 
reprocessed medical devices.
Reprocessing should be performed according 
to the instructions provided by the 
manufacturer and must follow technical 
specifications that ensure the conformity of  
the device at the time of its use towards the 
essential requirements of the apply Directive 
(INFARMED, 2008). This creates a difficult 
situation, as manufacturers’ instructions for 
single-use medical devices don’t indicate any 
reprocessing procedures.4
   xxxxxxxxxxxxxxxxxx
Table 1. Some European countries’ positions regarding the 
reprocessing of single-use medical devices
Permitted Not recommended Prohibited
Germany
Sweden
Belgium
Holland
Portugal
United Kingdom
Italy
Czech Republic
Austria
Spain
Ireland
France
 due to economic factors hospitals now practice the reprocessing 
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Challenges of 
reprocessing
Single-use medical devices are designed to be 
used only once, therefore, any reprocessing may 
damage or alter the device, potentially making it 
unsafe to reuse. Re-use can involve issues 
including infections, inability to clean and 
decontaminate residues such as from chemical 
decontamination products, material alteration and 
mechanical failure, and reactions to endotoxins 
(Abreu I, Abreu M J, Coelho A, 2014).
A satisfactory cleaning process must be able to 
access all parts of the device. If this is not 
possible then the device’s cleanliness is 
compromised and the risk of cross-infection 
may increase due to the inability of the 
reprocessing system to completely remove the 
viable microorganisms. For example, once in 
the device endotoxin (cell-associated gram-
negative bacteria) cannot be removed by 
cleaning, nor can it be inactivated by 
sterilisation, even when these two processes  
are effective in killing bacteria. 
Another problem related to cleanness and 
sterilisation is the chemical product used. Some 
materials can absorb or adsorb certain chemical 
agents and, in this way, device performance can 
be compromised, increasing patients’ risk of 
being in contact with malefic chemical agents. 
These chemical agents can cause corrosion and 
change the material, causing degradation. This 
can lead to mechanical failure and direct 
patient contact with the corroding and 
degrading products (Eucomed, 2009; 
INFARMED, 2010; MHRA, 2011).
On the other hand, reprocess and reuse of 
single-use medical devices can reduce costs to 
the health entity in a number of ways:
– By reducing the price of products, as on average 
a device undergoes five reprocessing cycles, saving 
around 50% per cycle (Bracklo, 2012)
– Reducing costs related to primary and secondary 
packaging and informative brochures, leading to 
decrease of hospital residues volume and better 
management of environmental recourses
– By avoiding non controlled and non-quality 
reprocessing (Neves, 2008)
The gains from the environmental impact of 
reprocessing procedure related to residues 
decreasing, however, can be annulled by the 
increase of resources consumed, like water and 
energy, and by the increased use of chemical 
products, sewage and intensive materials 
transportation (Mercedes, 2012).
Reprocessing 
in Portugal
In Portugal, reprocessing single-use medical 
devices is covered by national law Despacho 
7021/2013, of 24 May 2013, and must meet 
the following requirements:
– Traceability of the medical device from its first 
availability on the market as a single-use medical 
device, to its use as a reprocessed single-use  
medical device
– Correctly label the device in order to avoid potential 
mistake with non reprocessed devices
– The single-use medical device can only be 
reprocessed and used in accordance with Decreto-Lei 
145/2007, of 17 June 2007
February 2015
– The reprocessed devices can only be used in  
the National Health Service establishment  
(Serviço Nacional de Saúde, SNS) responsible  
for reprocessing
– The reprocessed device cannot be marketed in  
any form nor can it bear CE markings and 
associated information
– Information that it is a reprocessed single-use 
medical device and the number of reprocessing 
cycles already performed are mandatory – this 
endorsement must appear on the reprocessed device 
itself, or when this is not possible, on its primary 
packaging and any other level of packaging
Despacho 7021/2013 also mentions that the 
decision to use a reprocessed single-use 
medical device must evaluate the cost-
effectiveness of this practice, when realised in 
proper conditions of quality and safety, as well 
as considering direct and indirect costs and 
environmental impacts.
Conclusion 
Reprocessing and re-use of single-use  
medical devices raises questions about the 
safety, quality and correct performances of  
the product, which in turn create questions 
concerning ethics.
The healthcare system has been challenged to 
find equilibrium between patient rights and 
society’s goal to give health cost-benefit for 
everyone. Nowadays, legislation in the EU 
countries concerning the reprocessing of single-
use medical devices varies from member state 
to member state. In Portugal, reprocessing of 
single-use medical devices is accepted if the 
device’s quality and security are maintained. g
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